CD274 and small cell lung carcinoma: Therefore, we conducted a retrospective study to evaluate the efficacy of continuing IO in patients.<h4>Methods</h4>The study retrospectively collected clinical data of ES-SCLC patients as progressive disease (PD) after receiving first-line treatment with PD-1/PD-L1 inhibitors.